MAP1LC3A and rectal cancer: We next performed univariate analysis, the results of which indicated that LC3A SLS positivity in the TP was significantly associated with reduced OS (HR = 2.712, 95% CI: 1.470–5.009, p = 0.001, Table 4) in our cohort of rectal cancer patients.